Acute fulminant hepatitis after treatment with rabeprazole and terbinafine: Is rabeprazole the culprit?

被引:4
作者
Andrade, RJ
Lucena, MI
机构
关键词
D O I
10.1001/archinte.162.3.360
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:360 / 360
页数:1
相关论文
共 8 条
  • [1] Terbinafine and fulminant hepatic failure
    Agarwal, K
    Manas, DM
    Hudson, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (16) : 1292 - 1293
  • [2] Metabolism of the newer antidepressants - An overview of the pharmacological and pharmacokinetic implications
    Caccia, S
    [J]. CLINICAL PHARMACOKINETICS, 1998, 34 (04) : 281 - 302
  • [3] FARRELL GC, 1997, LIVER INJURY UPDATE, P37
  • [4] Gupta AK, 1998, CLIN EXP DERMATOL, V23, P64, DOI 10.1046/j.1365-2230.1998.00321.x
  • [5] Acute fulminant hepatitis after treatment with rabeprazole and terbinafine
    Johnstone, D
    Berger, C
    Fleckman, P
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (13) : 1677 - 1678
  • [6] Comparison of two clinical scales for causality assessment in hepatotoxicity
    Lucena, MA
    Camargo, R
    Andrade, RJ
    Perez-Sanchez, CJ
    De la Cuesta, FS
    [J]. HEPATOLOGY, 2001, 33 (01) : 123 - 130
  • [7] Effects of the antifungal agents on oxidative drug metabolism - Clinical relevance
    Venkatakrishnan, K
    von Moltke, LL
    Greenblatt, DJ
    [J]. CLINICAL PHARMACOKINETICS, 2000, 38 (02) : 111 - 180
  • [8] ZIMMERMAN HJ, 1988, ADVERSE EFFECTS DRUG